Tisento Therapeutics has received fast track designation from the US Food and Drug Administration (FDA) for zagociguat.

FDA Commissioner Dr Marty Makary tried to allay industry concerns about recent cuts and outlined his agenda for the future.

India has proposed increasing US manufacturing by Indian pharma providers of APIs and the final stages of drug processing ...

Orion Corporation has broadened its partnership with Glykos, focusing on the development of antibody-drug conjugates (ADCs).

The FDA launched a new Priority Review program, as uncertainty persists for the existing programme for paediatric disorders.

Novo Nordisk is looking to partner with digital companies at every stage of the weight loss journey to help patients lose ...

Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising ...

Lisata Therapeutics has formed a strategic partnership with GATC Health for advancing AI-driven drug discovery and ...

The test is currently available in private healthcare facilities but there are hopes it may be adopted by the NHS.

European companies must be able to provide developed and scalable business models if they want to enter the US to manage the ...

Supply chains for a new generation of therapies are complex, costly, and require meticulous management to ensure patient ...

European biotechs have historically struggled to find capital on the continent, but the funding ecosystem now aims to scale ...